CAAS Capital Management’s OptiNose OPTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-13,870
Closed -$861K 1343
2020
Q4
$861K Sell
13,870
-12,037
-46% -$737K 0.01% 629
2020
Q3
$1.52M Buy
+25,907
New +$1.92M 0.04% 291
2020
Q2
Sell
-5,255
Closed -$354K 452
2020
Q1
$354K Buy
+5,255
New +$529K 0.04% 184

Other funds holding OPTN

CAAS Capital Management's OPTN Position: Q1 2021 in Review

CAAS Capital Management sold out of OptiNose (OPTN) in Q1 2021, closing a stake of 13,870 shares — an estimated $861K sold.

CAAS Capital Management first reported a position in OPTN in Q1 2020 and held it in 3 quarters. The position peaked at $1.52M in Q3 2020. 68 funds tracked by Wall St. Rank hold OPTN as of Q1 2021.

  • CAAS Capital Management reported no remaining OptiNose position as of Q1 2021 after selling out during the quarter.
  • CAAS Capital Management sold 13,870 OptiNose shares in Q1 2021, an estimated $861K.
  • CAAS Capital Management first reported a position in OptiNose in Q1 2020 and held it in 3 quarters.
  • CAAS Capital Management's OptiNose position peaked at $1.52M in Q3 2020.
  • 68 funds tracked by Wall St. Rank held OptiNose as of Q1 2021.

Based on CAAS Capital Management's 13F filing for Q1 2021, filed 17 May 2021.